BOCA RATON, Fla., March 27, 2018 /PRNewswire/ — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years. The investigators theorize the levels declined over time as a result […]
Coronary/Structural Heart
Renova Therapeutics Announces Issuance of Patent Covering Delivery and Expression of Paracrine Genes
SAN DIEGO, March 27, 2018 /PRNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the European Patent Office has issued Patent No. 2814513, “Systemic Delivery and Regulated Expression of Paracrine Genes for Cardiovascular Diseases and Other Conditions” to The Regents of the […]
Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid
WASHINGTON, March 23, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the United States Patent and Trademark Office (USPTO) decided in Edwards’ favor in an Inter Partes Review (IPR) of Boston Scientific’s U.S. transcatheter heart valve patent, […]
North America Electrocardiograph (ECG) Market Analysis 2017-2023 – Resting ECG, Stress ECG, and Holter Monitors – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Electrocardiograph (ECG) Market is expected to witness market growth of 4.9% CAGR during the forecast period (2017 – 2023). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over […]
North America Vascular Graft Market Analysis 2017-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Vascular Graft Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Vascular Graft Market is expected to witness market growth of 5.4% CAGR during the forecast period (2017 – 2023). A vascular graft is a medical device which is used as an artificial blood vessel. These […]
Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis & Outlook 2018-2022 with Profiles of Abbott Laboratories, Boston Scientific, Edwards Lifesciences & Medtronic – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The global TAVI market is expected to grow in future due […]
JenaValve Technology Appoints Keith D. Dawkins, M.D., as Board Member
IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]
LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has announced the first patient enrollment in the Perceval® Valve Clinical study for Chinese Registration (“PERFECT”) Trial. The study is a pre-market, prospective, single-arm trial. The PERFECT trial is being conducted to demonstrate the safety and effectiveness of […]
Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe
IRVINE, Calif., March 21, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve. This randomized sub-study is examining […]
Recent
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
Popular
- No commented posts yet